Literature DB >> 23630117

Acidic pH-responsive siRNA conjugate for reversible carrier stability and accelerated endosomal escape with reduced IFNα-associated immune response.

Hiroyasu Takemoto1, Kanjiro Miyata, Shota Hattori, Takehiko Ishii, Tomoya Suma, Satoshi Uchida, Nobuhiro Nishiyama, Kazunori Kataoka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23630117     DOI： 10.1002/anie.201300178

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  15 in total

1.  Development of siRNA Therapeutics for the Treatment of Liver Diseases.

Authors:  Anja Holm; Marianne Bengtson Løvendorf; Sakari Kauppinen
Journal:  Methods Mol Biol       Date:  2021

2.  ATP-responsive DNA-graphene hybrid nanoaggregates for anticancer drug delivery.

Authors:  Ran Mo; Tianyue Jiang; Wujin Sun; Zhen Gu
Journal:  Biomaterials       Date:  2015-02-14       Impact factor: 12.479

3.  Histamine-functionalized copolymer micelles as a drug delivery system in 2D and 3D models of breast cancer.

Authors:  Yuning Zhang; Pontus Lundberg; Maren Diether; Christian Porsch; Caroline Janson; Nathaniel A Lynd; Cosimo Ducani; Michael Malkoch; Eva Malmström; Craig J Hawker; Andreas M Nyström
Journal:  J Mater Chem B       Date:  2015-03-28       Impact factor: 6.331

4.  Self-assembled nanoscale coordination polymers carrying siRNAs and cisplatin for effective treatment of resistant ovarian cancer.

Authors:  Chunbai He; Demin Liu; Wenbin Lin
Journal:  Biomaterials       Date:  2014-10-12       Impact factor: 12.479

5.  Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy.

Authors:  Hong-Jun Li; Jin-Zhi Du; Xiao-Jiao Du; Cong-Fei Xu; Chun-Yang Sun; Hong-Xia Wang; Zhi-Ting Cao; Xian-Zhu Yang; Yan-Hua Zhu; Shuming Nie; Jun Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

6.  The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.

Authors:  Ke Gong; Juyang Jiao; Chaoqun Xu; Yang Dong; Dongxiao Li; Di He; Jian Yu; Ying Sun; Wei Zhang; Min Bai; Yourong Duan
Journal:  J Nanobiotechnology       Date:  2021-05-31       Impact factor: 10.435

7.  New side chain design for pH-responsive block copolymers for drug delivery.

Authors:  Priyanka Ray; Narendra Kale; Mohiuddin Quadir
Journal:  Colloids Surf B Biointerfaces       Date:  2021-01-06       Impact factor: 5.999

8.  Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon.

Authors:  Yan Li; Ruiyuan Liu; Yuanjie Shi; Zhenzhong Zhang; Xin Zhang
Journal:  Theranostics       Date:  2015-02-27       Impact factor: 11.556

9.  Polysaccharide Nanoparticles for Efficient siRNA Targeting in Cancer Cells by Supramolecular pKa Shift.

Authors:  Ying-Ming Zhang; Yang Yang; Yu-Hui Zhang; Yu Liu
Journal:  Sci Rep       Date:  2016-07-01       Impact factor: 4.379

Review 10.  Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates.

Authors:  Santiago Grijalvo; Adele Alagia; Andreia F Jorge; Ramon Eritja
Journal:  Genes (Basel)       Date:  2018-02-06       Impact factor: 4.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.